https://www.selleckchem.com/pr....oducts/cobimetinib-g
system. This article is protected by copyright. All rights reserved. Aim of this study is to evaluate short term safety and efficacy of Impella in high risk percutaneous coronary intervention (HR-PCI) population. While several studies demonstrated the clinical significance of Impella in HR-PCI, few data exist about its impact on short term outcome. All studies reporting short term outcomes of PCI with any Impella device were included. The primary endpoint was either in-hospital or 30-day mortality, while vascular com
Like
Comment
Share
